Oral Iron Therapy for Iron‑Deficiency Anemia: Dosing, Timing, Monitoring, and Transition to Intravenous Iron

Initial Prescription and Choice of Salt

• Ferrous sulfate 200 mg (≈65 mg elemental iron) taken once daily on an empty stomach is the most cost‑effective first‑line oral regimen, providing 50–100 mg elemental iron per dose and should be continued for 2–3 months after hemoglobin normalizes to replenish iron stores【1】【2】.
• When ferrous sulfate is unavailable, ferrous gluconate or ferrous fumarate are equally effective alternatives【2】【3】.

Dosing Frequency

• Once‑daily dosing is superior to multiple daily doses because a single iron dose raises hepcidin, which remains elevated for ~48 h, blocking further absorption and increasing gastrointestinal side effects without added benefit【1】.
• For patients experiencing significant nausea or other gastrointestinal adverse effects, an alternate‑day regimen of ~120 mg elemental iron every other day yields comparable hemoglobin gains while halving the risk of GI adverse events (RR ≈ 0.56) and improves adherence, although iron‑store repletion may be slightly slower【2】.

Timing and Administration

• Iron should be taken in the morning on an empty stomach to maximize absorption【1】【2】.
• If intolerance occurs, iron may be taken with meals (recognizing reduced absorption) or with meat protein to enhance uptake【1】.

Vitamin C Co‑supplementation

• Vitamin C is optional; it can modestly increase iron absorption. When used, 500 mg vitamin C taken separately from iron or consumption of vitamin C‑rich foods is recommended【1】.
• Recent evidence indicates that vitamin C is not essential for successful treatment, despite earlier guideline emphasis【3】.

Monitoring Schedule

• Hemoglobin should be re‑checked at 2 weeks; a rise of <10 g/L predicts subsequent treatment failure with 90 % sensitivity and 79 % specificity【2】.
• Subsequent hemoglobin assessments are performed every 4 weeks until normalization【2】.
• After hemoglobin correction, continue oral iron for an additional 2–3 months to restore iron stores【2】【3】.
• Red‑cell indices and hemoglobin are monitored every 3 months during the first year, then every 6–12 months to detect recurrence【3】.

Indications for Switching to Intravenous Iron

• Inadequate hemoglobin response (<10 g/L rise) after 2 weeks of oral therapy【2】.
• Clinically active inflammatory bowel disease or other gastrointestinal inflammatory conditions where parenteral iron is more effective【2】【4】.
• Presentation hemoglobin <100 g/L【4】.
• Presence of chronic disease, ongoing blood loss, or malabsorption that limits oral iron efficacy【2】.
• Patient preference when severe oral intolerance is present【2】.

Common Pitfalls to Avoid

• Do not prescribe multiple daily doses; this increases side effects without improving absorption due to hepcidin‑mediated blockade【1】.
• Do not switch between different ferrous salts for intolerance; instead consider alternate‑day dosing, ferric maltol, or intravenous iron【1】【2】.
• Do not use modified‑release iron preparations; they are less suitable for effective therapy【2】.
• Do not rely on fecal occult blood testing for identifying the cause of iron deficiency, as it is insensitive and nonspecific【3】.
• Always investigate underlying etiologies such as menstrual loss, dietary insufficiency, celiac disease, Helicobacter pylori infection, or gastrointestinal bleeding【1】【2】【3】.

Special Populations

• Premenopausal women with heavy menstrual bleeding should receive oral iron as first‑line therapy; persistent anemia despite adequate supplementation warrants gynecologic evaluation【3】.
• Patients with inflammatory bowel disease should receive intravenous iron as first‑line when disease is active, hemoglobin is <100 g/L, or prior oral intolerance occurred【4】.

Expected Clinical Response

• Hemoglobin is expected to increase by at least 10 g/L within 2 weeks and to normalize within 4–8 weeks of appropriate oral therapy【2】.
• Correction of anemia leads to measurable improvements in quality of life, independent of the underlying disease activity【4】.

Guideline Recommendations for Oral Iron Therapy in Iron‑Deficiency Anemia

Prescription Iron Selection

• For adults with persistent iron deficiency (e.g., ferritin ≈ 22 ng/mL after OTC iron), prescribe ferrous sulfate 200 mg (≈ 65 mg elemental iron) once daily on an empty stomach; a combined iron‑vitamin C product is not required. 5

• The British Society of Gastroenterology (2021) recommends an initial oral regimen of 50–100 mg elemental iron (one ferrous‑sulfate 200 mg tablet) taken in the fasting state. 6

• Ferrous sulfate 200 mg tablets are the most cost‑effective first‑line option; ferrous gluconate and ferrous fumarate provide comparable efficacy. 7

Dosing Strategies

• Once‑daily dosing is superior to multiple daily doses because hepcidin rises after iron intake and remains elevated for up to 48 h, limiting further absorption. 8

• Fasting administration maximizes iron absorption, although some patients may tolerate intake with meals if necessary. 8

• Alternate‑day dosing (≈ 120 mg elemental iron every other day) yields hemoglobin increments similar to daily dosing but with markedly lower nausea; it may be less rapid for repleting iron stores. 9

Vitamin C Considerations

• Earlier guidelines suggested ascorbic acid enhances iron absorption, but recent evidence is mixed; a 2024 AGA update notes that 80 mg vitamin C on an empty stomach may improve absorption, yet further study is required. 8

• Vitamin C supplementation is optional: patients may take 500 mg vitamin C separately or consume vitamin‑C‑rich foods to modestly aid absorption, but it is not essential for treatment success. 8

Monitoring and Follow‑up

• Re‑check hemoglobin 2–4 weeks after starting therapy; failure to achieve at least a 10 g/L (1 g/dL) rise after 2 weeks predicts subsequent treatment failure with ~90 % sensitivity. 9

• Continue hemoglobin monitoring every 4 weeks until values normalize. 6

• After hemoglobin correction, maintain oral iron for an additional 2–3 months to replenish iron stores. 5

• Perform a complete blood count every 3 months for the first year, then every 6–12 months thereafter. 7

Indications for Intravenous Iron

• Switch to IV iron when any of the following occur:

• Available IV formulations include ferric carboxymaltose (single 1000 mg dose, 15‑minute infusion), ferric derisomaltose, iron sucrose, and iron dextran. 9

Common Pitfalls to Avoid

• Do not prescribe multiple daily doses; this increases gastrointestinal side effects without improving absorption due to hepcidin‑mediated blockade. 8

• Do not switch between different ferrous salts for intolerance; consider alternate‑day dosing, ferric maltol, or IV iron instead. 11

• Always investigate the underlying cause of iron deficiency (e.g., menstrual loss, dietary insufficiency, celiac disease, H. pylori infection). 8

• Avoid tea or coffee within 1 hour of iron ingestion, as they markedly inhibit absorption. 8